ARCHIVES

FDA Advisors Okay NCI Toxicology Proposals, Write New Clinical Guidelines, Approve AIN DA

This article is from The Cancer Letter archive.

Vol. 05 No. 42 | October 19, 1979

Download PDF Visit The Full Archive

Related Articles

NCI To Proceed With Guidelines Unless Board Strongly Disagree

May 9, 1980

FDA Approves Gemzar For Ovarian Cancer, Contradicting ODAC Recommendation; Continues Agency Trend to Recognize Progression-Free Survival As An Endpoint.

July 21, 2006

Taxol Issue Prompts Questions Forom Reader

July 26, 1991

Funding Opportunities. (8-page issue).

May 2, 2003

FDA Working On New Ground Rules For “Adaptive” Clinical Trial Designs.

July 14, 2006

Obituary: Michael Potter, 89, NIH Researcher

June 26, 2013